169 related articles for article (PubMed ID: 33962995)
1. Incorporating molecular profiling into endometrial cancer management requires prospective studies.
Amant F; McCluggage WG; Werner HMJ; Kasius JC; Krakstad C; Pijnenborg J
Int J Gynecol Cancer; 2021 Jun; 31(6):944-945. PubMed ID: 33962995
[No Abstract] [Full Text] [Related]
2. [Endometrial carcinoma - molecular pathogenesis meets histomorphology and treatment].
Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):1-2. PubMed ID: 11873306
[No Abstract] [Full Text] [Related]
3. [Preinvasive lesions in gynaecology - endometrium].
Feranec R; Mouková L; Chovanec J
Klin Onkol; 2013; 26 Suppl():S52-3. PubMed ID: 24325166
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Chung YS; Woo HY; Lee JY; Park E; Nam EJ; Kim S; Kim SW; Kim YT
Am J Obstet Gynecol; 2021 Apr; 224(4):370.e1-370.e13. PubMed ID: 33039397
[TBL] [Abstract][Full Text] [Related]
5. Risk of endometrial cancer in asymptomatic postmenopausal patients with thickened endometrium: data from the FAME-Endo study: an observational register study.
Hefler L; Lafleur J; Kickmaier S; Leipold H; Siebenhofer C; Tringler B; Schauer C; Ciresa-König A; Reinthaller A
Arch Gynecol Obstet; 2018 Oct; 298(4):813-820. PubMed ID: 30182190
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer: molecular and therapeutic aspects.
Tsikouras P; Bouchlariotou S; Vrachnis N; Dafopoulos A; Galazios G; Csorba R; von Tempelhoff GF
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):1-9. PubMed ID: 23433742
[TBL] [Abstract][Full Text] [Related]
7. Optimal therapy and management of endometrial cancer.
Sonoda Y
Expert Rev Anticancer Ther; 2003 Feb; 3(1):37-47. PubMed ID: 12597348
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors of cancer of the endometrium and therapeutic implications].
Michel G; Morice P; Castaigne D; Lanoux P; Pautier P; Lhommé C; Gerbaulet A; Duvillard P
Contracept Fertil Sex; 1998 Jun; 26(6):452-6. PubMed ID: 9691524
[TBL] [Abstract][Full Text] [Related]
9. Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients.
Berstein LM; Bakhidze EV; Evtushenko TP; Gamajunova VB; Krjukova OG; Kovalenko IG; Tsyrlina EV; Bokhman JaV
Mutat Res; 1996 Sep; 356(2):203-8. PubMed ID: 8841486
[TBL] [Abstract][Full Text] [Related]
10. [A study of Bcl-2 expression in normal endometrium and endometrial carcinoma].
Zheng Y; Peng Z; Wang H
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):92-5. PubMed ID: 12205937
[TBL] [Abstract][Full Text] [Related]
11. Autotaxin is a novel molecular identifier of type I endometrial cancer.
Mazzocca A; Schönauer LM; De Nola R; Lippolis A; Marrano T; Loverro M; Sabbà C; Di Naro E
Med Oncol; 2018 Oct; 35(12):157. PubMed ID: 30374843
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability and immunohistochemical analysis of MLH1 and MSH2 in normal endometrium, endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis colorectal cancer patient.
Ichikawa Y; Tsunoda H; Takano K; Oki A; Yoshikawa H
Jpn J Clin Oncol; 2002 Mar; 32(3):110-2. PubMed ID: 11956307
[TBL] [Abstract][Full Text] [Related]
13. The role of pathology in the management of patients with endometrial carcinoma.
Bartosch C; Pires M; Jerónimo C; Lopes JM
Future Oncol; 2017 May; 13(11):1003-1020. PubMed ID: 28481146
[TBL] [Abstract][Full Text] [Related]
14. Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer.
Cummings M; Massey KA; Mappa G; Wilkinson N; Hutson R; Munot S; Saidi S; Nugent D; Broadhead T; Wright AI; Barber S; Nicolaou A; Orsi NM
J Pathol; 2019 Jan; 247(1):21-34. PubMed ID: 30168128
[TBL] [Abstract][Full Text] [Related]
15. Exosomal transfer of functional small RNAs mediates cancer-stroma communication in human endometrium.
Maida Y; Takakura M; Nishiuchi T; Yoshimoto T; Kyo S
Cancer Med; 2016 Feb; 5(2):304-14. PubMed ID: 26700550
[TBL] [Abstract][Full Text] [Related]
16. DNA Methylation Machinery in the Endometrium and Endometrial Cancer.
Caplakova V; Babusikova E; Blahovcova E; Balharek T; Zelieskova M; Hatok J
Anticancer Res; 2016 Sep; 36(9):4407-20. PubMed ID: 27630276
[TBL] [Abstract][Full Text] [Related]
17. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
19. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
20. [Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor messenger RNA in human endometrium and endometrial carcinoma].
Sato A; Bo M; Otani T; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1995 May; 47(5):473-8. PubMed ID: 7775814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
